The global distribution of Pfizer and BioNTech’s COVID-19 vaccine will be monitored and tracked by Icelandic company Controlant, the company announced in a press release yesterday. Controlant’s technology will track vaccine shipments in real time, while capturing environmental information such as temperature, allowing stakeholders to monitor and manage shipments more closely and reducing product loss, tampering or spoilage. The Icelandic company is also working directly with the US Government on their vaccination initiative Operation Warp Speed.
“Controlant IoT devices, packed with the vaccines, capture environmental information, including time, temperature, and light events, and send the information, in real-time, to Controlant’s proprietary cloud-enabled software and analytics platform, where designated stakeholders can view and receive alerts and react to live temperature and location data on demand,” the press release from the company reads. Controlant currently monitors shipments of pharmaceuticals & life sciences and food & beverage products to over 115 countries worldwide.
Working Directly With US Government
In addition to the visibility and monitoring solutions that Controlant is providing to Pfizer for mRNA-based Pfizer-BioNTech COVID-19 vaccine distribution supply chain, the company is also working directly with the U.S. Government and health officials, such as the Center for Disease Control (CDC), U.S. Department of Health and Human Services (HHS), and stakeholders in Operation Warp Speed, to provide on-site monitoring at U.S. Government-preferred designated vaccination locations to help seamlessly ensure continuity during hand-off, actionable communication, and visibility, throughout the entirety of the U.S. supply chain journey of the vaccines.
“Controlant has amassed a depth of expertise in vaccine supply chain operations and we are happy to have the opportunity to apply our solutions to the entirety of the mRNA-based Pfizer-BioNTech COVID-19 vaccine supply chain, through our direct work with Pfizer and government stakeholders,” said Gísli Herjólfsson, Co-founder and CEO of Controlant. “We have built and continue to build products and services to prepare for and meet the changing demands of the pharmaceutical and life sciences industries, including real-time and automated solutions, while helping brands, manufacturers, and logistics providers in these market segments ensure and maintain regulatory compliance and product integrity.”
Controlant received the Icelandic Government’s Innovation Award earlier this year.